Abiomed announces new Impella device, plan for Japan | Wall Street Beat
December 19, 2011 by MassDevice staff
Abiomed hopes to add a new ventricular assist device to its Impella line of heart pumps next year and plans to enter the Japanese market in 2013; also, Abbott, BSX facing new stent rival?; Baxter closes $500M bond deal; and analysts' ups & downs.
Amid celebrating the first human use of its Symphony implantable heart pump for chronic heart failure patients, Abiomed (NSDQ:ABMD) unveiled a new ventricular assist device for its flagship Impella line of heart pumps.
Announced at the company's annual investors' day in New York, the new device is slated to hit the market some time next summer. Abiomed also has its sights set on entering the Japanese market in 2013.
Similar entries
- Show full page
- Login to post comments
-
Permalink
FDA Database Search
RECENT BLOG POSTS
- Funding R&D: High prices, overuse a failed strategy
- FDA's role in promoting women's health
- New partnership to boost use of GMDN codes for medical devices
- FDA's modern "Corps of Discovery" in China
- Consumers lose in latest FDA user fee bill; COI restraints disappear
- Gamification
- Cool technology of the week
- A new day: Interim thoughts on the 2012 Heart Rhythm Society scientific sessions
- When a child loses milestones, consider sleep EEG studies
- Red or blue pill for payment reform? Both won't work
NEWS
EuroPCR: Warnings on TAVI in replacing surgically implanted prosthetic valves
Transcatheter aortic valve implantation proves successful in reinforcing failed valve prosthetics,...
Weight loss: Surgery triggers rare metabolic wasting disease | MassDevice.com On Call
A rare but deadly genetic mutation that prevents the body from absorbing protein can be set off by...
Medical device tax: Ohio's industry pushes repeal while GOP group gets hyper-political
Ohio-based medical device makers meet with local legislators to discuss efforts to repeal the...
MassDevice.com +3 | The top 3 med-tech stories for May 15, 2012.
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed CEO Robert Hansen retires after 20 years at the helm | Personnel Moves
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...
